Table 1 Basic demographic and clinical data of 411 patients with HCC
Clinical features | HCC(n = 411) | N-HCC(n = 104) | A-HCC (n = 307) | OR (95%CI) | P value |
|---|---|---|---|---|---|
Age, n(%) | Â | Â | Â | Â | Â |
 ≤ 60years | 266 (64.72%) | 52 (50.00%) | 214 (69.71%) | 301 (1.460–3.627) | 0.000 |
 > 60years | 145 (35.28%) | 52 (50.00%) | 93 (30.29%) | ||
Gender, n(%) | Â | Â | Â | Â | Â |
 Male | 356 (86.62%) | 96 (92.31%) | 260 (84.69%) | 0.461 (0.210–1.011) | 0.049 |
 Female | 55 (13.38%) | 8 (7.69%) | 47 (15.31%) | ||
Cirrhosis, n(%) | Â | Â | Â | Â | Â |
 Yes | 267 (64.96%) | 70 (67.31%) | 197 (64.17%) | 0.870 (0.543–1.394) | 0.562 |
 No | 144 (35.04%) | 34 (32.69%) | 110 (35.83%) | ||
TNM stage, n(%) | Â | Â | Â | Â | Â |
 Stage I | 76 (18.49%) | 37 (35.58%) | 39 (12.70%) | 0.496 (0.389–0.633) | 0.000 |
 Stage II | 75 (18.25%) | 27 (25.96%) | 48 (15.64%) | ||
 Stage III | 199 (48.42%) | 30 (28.85%) | 169 (55.05%) | ||
 Stage IV | 61 (14.84%) | 10 (9.61%) | 51 (16.61%) | ||
Tumor size, n(%) | Â | Â | Â | Â | Â |
 < 3 cm | 59 (14.36%) | 29 (27.89%) | 30 (9.77%) | 0.391 (0.289–0.530) | 0.000 |
 3–5 cm | 116 (28.22%) | 42 (40.38%) | 74 (24.11%) | ||
 > 5 cm | 236 (57.42%) | 33 (31.73%) | 203 (66.12%) | ||
Daughter nodule, n(%) | Â | Â | Â | Â | Â |
 Yes | 216 (52.55%) | 49 (47.12%) | 167 (54.40%) | 0.747 (0.478–1.166) | 0.199 |
 No | 195 (47.45%) | 55 (52.88%) | 140 (45.60%) | ||
Intrahepatic metastasis, n(%) | Â | Â | Â | Â | Â |
 Yes | 209 (50.85%) | 34 (32.69%) | 175 (57.00%) | 2.730 (1.710–4.358) | 0.000 |
 No | 202 (49.15%) | 70 (67.31%) | 132 (43.00%) | ||
Distant metastasis, n(%) | Â | Â | Â | Â | Â |
 Yes | 114 (27.74%) | 21(20.19%) | 93 (30.29%) | 1.718 (1.004–2.939) | 0.047 |
 No | 297 (72.26%) | 83(79.81%) | 214 (69.71%) |